Company · CIK 0001819790 · SIC 2836 — Biological Products, (No Diagnostic Substances) · Nasdaq

Tarsus Pharmaceuticals, Inc. · TARS

Insider activity reported against this company. All insider holders · On EDGAR ↗

Period1M 3M 6M 1Y 2Y All datashares as filed — not split-adjusted

Open-market buys & salesbuys $0 · 0sales $5.2M · 6net −$5.2M

Reported at this company — common stock

Trade	Reported (ET)	Insider	Shares	Avg price	Total	Owned after	Δ stake	Flags
Sep 15, 2026 MForm 4 →	Sep 17, 4:47 pm EDT	David E I PyottDirector	201	—	—	9,575	—
Sep 15, 2026 MForm 4 →	Sep 17, 4:22 pm EDT	Wendy L YarnoDirector	302	—	—	16,956	—
Sep 15, 2026 SForm 4 →	Sep 17, 4:22 pm EDT	William J Link Ph.D.Director	12,500	$78.38	$979,744	94,487	−11.7%	10b5-1
Sep 15, 2026 MForm 4 →	Sep 17, 4:22 pm EDT	William J Link Ph.D.Director	201	—	—	106,987	—	10b5-1
Sep 4, 2026 SForm 4 →	Sep 9, 4:14 pm EDT	Bobak R. AzamianPresident/CEO and Board Chair, Director	10,000	$90.56	$905,600	827,991	−1.19%	10b5-1
Sep 4, 2026 SForm 4 →	Sep 9, 4:13 pm EDT	Elizabeth Yeu LinChief Medical Officer	13,953	$87.50	$1,220,885	1,590	−89.8%	10b5-1
Sep 4, 2026 SForm 4 →	Sep 9, 4:12 pm EDT	Seshadri NeervannanChief Operating Officer	4,564	$85.00	$387,940	78,532	−5.49%	10b5-1
Sep 2, 2026 SForm 4 →	Sep 3, 4:30 pm EDT	Bobak R. AzamianPresident/CEO and Board Chair, Director	10,000	$80.06	$800,600	837,991	−1.18%	10b5-1
Sep 1, 2026 SForm 4 →	Sep 3, 4:29 pm EDT	Elizabeth Yeu LinChief Medical Officer	11,578	$77.56	$897,990	4,770	−70.8%	10b5-1

Trade	Reported (ET)	Insider	Shares	Avg price	Total	Owned after	Δ stake	Flags
Sep 15, 2026 MForm 4 →	Sep 17, 4:47 pm EDT	David E I PyottDirector	201	—	—	605	—
Sep 15, 2026 MForm 4 →	Sep 17, 4:22 pm EDT	Wendy L YarnoDirector	302	—	—	907	—
Sep 15, 2026 MForm 4 →	Sep 17, 4:22 pm EDT	William J Link Ph.D.Director	201	—	—	605	—	10b5-1